Free Trial

Jane Prior Sells 10,000 Shares of Vita Coco Company, Inc. (NASDAQ:COCO) Stock

Vita Coco logo with Consumer Staples background

Vita Coco Company, Inc. (NASDAQ:COCO - Get Free Report) CMO Jane Prior sold 10,000 shares of the company's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $37.07, for a total transaction of $370,700.00. Following the completion of the transaction, the chief marketing officer directly owned 134,188 shares of the company's stock, valued at approximately $4,974,349.16. The trade was a 6.94% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Jane Prior also recently made the following trade(s):

  • On Wednesday, June 18th, Jane Prior sold 10,000 shares of Vita Coco stock. The shares were sold at an average price of $35.12, for a total value of $351,200.00.

Vita Coco Stock Performance

Shares of COCO traded up $0.56 during mid-day trading on Friday, reaching $37.75. 260,334 shares of the company's stock traded hands, compared to its average volume of 616,578. The business's 50-day moving average price is $34.95 and its 200-day moving average price is $34.69. The stock has a market capitalization of $2.14 billion, a P/E ratio of 37.38, a price-to-earnings-growth ratio of 1.98 and a beta of 0.37. Vita Coco Company, Inc. has a 12 month low of $23.56 and a 12 month high of $40.32.

Vita Coco (NASDAQ:COCO - Get Free Report) last announced its earnings results on Wednesday, April 30th. The company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.09. Vita Coco had a return on equity of 25.08% and a net margin of 11.32%. The firm had revenue of $130.92 million for the quarter, compared to the consensus estimate of $125.64 million. During the same quarter in the previous year, the business earned $0.24 EPS. The firm's revenue for the quarter was up 17.2% on a year-over-year basis. Equities research analysts anticipate that Vita Coco Company, Inc. will post 1.07 EPS for the current year.

Analyst Ratings Changes

COCO has been the subject of several research analyst reports. Stephens reiterated an "equal weight" rating and set a $32.00 target price on shares of Vita Coco in a research note on Thursday, March 27th. Wall Street Zen downgraded shares of Vita Coco from a "buy" rating to a "hold" rating in a research note on Saturday, June 7th. Wells Fargo & Company boosted their target price on shares of Vita Coco from $39.00 to $43.00 and gave the stock an "overweight" rating in a research report on Friday, May 30th. The Goldman Sachs Group set a $41.00 target price on shares of Vita Coco and gave the company a "buy" rating in a research note on Wednesday, April 30th. Finally, Evercore ISI lifted their price target on Vita Coco from $35.00 to $38.00 and gave the stock an "outperform" rating in a research note on Thursday, May 1st. Four research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $35.88.

View Our Latest Stock Analysis on COCO

Hedge Funds Weigh In On Vita Coco

Several large investors have recently bought and sold shares of the stock. Coppell Advisory Solutions LLC boosted its holdings in shares of Vita Coco by 91.5% in the fourth quarter. Coppell Advisory Solutions LLC now owns 1,283 shares of the company's stock valued at $47,000 after acquiring an additional 613 shares in the last quarter. CWM LLC lifted its position in Vita Coco by 14.7% in the first quarter. CWM LLC now owns 2,868 shares of the company's stock worth $88,000 after purchasing an additional 367 shares during the period. Militia Capital Partners LP boosted its stake in Vita Coco by 60.0% during the 1st quarter. Militia Capital Partners LP now owns 3,200 shares of the company's stock valued at $98,000 after purchasing an additional 1,200 shares in the last quarter. Caitong International Asset Management Co. Ltd acquired a new position in shares of Vita Coco during the 1st quarter valued at $111,000. Finally, Summit Investment Advisors Inc. raised its stake in shares of Vita Coco by 9.2% in the 4th quarter. Summit Investment Advisors Inc. now owns 4,107 shares of the company's stock worth $152,000 after buying an additional 347 shares in the last quarter. Institutional investors and hedge funds own 88.49% of the company's stock.

Vita Coco Company Profile

(Get Free Report)

The Vita Coco Company, Inc develops, markets, and distributes coconut water products under the Vita Coco brand name in the United States, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company offers coconut oil and coconut milk; juice; Runa, a plant-based energy drink; packaged water under the Ever & Ever brand name; and PWR LIFT, a protein-infused fitness drink.

Read More

Insider Buying and Selling by Quarter for Vita Coco (NASDAQ:COCO)

Should You Invest $1,000 in Vita Coco Right Now?

Before you consider Vita Coco, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vita Coco wasn't on the list.

While Vita Coco currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines